Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Best Case Scenario for PMN

View:

Post by DavidKingCanada on Jul 20, 2021 4:11pm

Best Case Scenario for PMN

Would like to hear what others may be thinking;

PMN is a small Canadian Company with a very small Cap and almost no pull in the Industry.

If PMN becomes successful in creating and manufacturing a Serology Test or an actual working and FDA Approved Drug to treat Alzheimers they may and most likely be bought out by much larger US Companies before we can see any Increase in SP.

In all honesty, I don't see PMN holding the torch and running with it.

PMN has "proprietary" Software like many other Companies have stated. How much "proprietary" they have is how much they will be paid.

136

Comment

Comment by DavidKingCanada on Jul 20, 2021 4:18pm

Datametrix DM.V has already produced a Covid 19 Test and that has carried them over this year. DM has Revenue which PMN does not. DM is trading at the same SP with Revenue! The only way PMN will rise is if they find the "cure" to Alzheimers. Manufacturing and Producing a Covid 19 Serology Test at this point makes no sense. Any thoughts?

Comment

Comment by KingAbeNYC on Jul 20, 2021 4:24pm

I really hope your right, I also believe in this company. Do you really think a new Ceo will change management and the overall direction? This Year the PR's have been great. But I agree with M101, lets stop white washing Biogen. PMN to the Moon!

Comment

Comment by DavidKingCanada on Jul 20, 2021 4:31pm

Well to be honest, I am hoping that a new CEO will change direction and make things work. Tbh, I really don't mind the current Board but a new CEO might make things better. imagine this; new fda drug approved and a new and ambitious CEO!

Comment

Comment by Gbathat on Jul 20, 2021 6:38pm

Please compare market caps rather than share price, since market cap reflects the value of the company. In this case, the market caps are also similar, because the number of shares available is similar. PMN valuation should be based on future earnings expectations, regardless of the product involved. A COVID serology test that is widely used could generate substantial revenues, especially ...more

Comment

Comment by DavidKingCanada on Jul 20, 2021 8:31pm

Gbathat, sorry should have stated the Company that I stated has the same Market Cap and also the same SP as PMN.

Comment

Comment by Gbathat on Jul 20, 2021 9:44pm

all good DKC. I figured as much and did not mean that to read as critical or anything. thanks for helping to keep the chatter going and dd flowing around here. I've been slacking on my dd lately and need to catch up. Good luck to you.

Comment